NXGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NXGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Days Inventory is also known as Days Sales of Inventory (DSI). NextGen Healthcare's Average Total Inventories for the three months ended in Sep. 2023 was $0.0 Mil. NextGen Healthcare's Cost of Goods Sold for the three months ended in Sep. 2023 was $94.8 Mil. Hence, NextGen Healthcare's Days Inventory for the three months ended in Sep. 2023 was 0.00.
The historical rank and industry rank for NextGen Healthcare's Days Inventory or its related term are showing as below:
During the past 13 years, NextGen Healthcare's highest Days Inventory was 1.28. The lowest was 0.26. And the median was 0.77.
NextGen Healthcare's Days Inventory stayed the same from Sep. 2022 (0.00) to Sep. 2023 (0.00).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. NextGen Healthcare's Inventory-to-Revenue for the three months ended in Sep. 2023 was 0.00.
The historical data trend for NextGen Healthcare's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NextGen Healthcare Annual Data | |||||||||||||||||||||
Trend | Mar14 | Mar15 | Mar16 | Mar17 | Mar18 | Mar19 | Mar20 | Mar21 | Mar22 | Mar23 | |||||||||||
Days Inventory | Get a 7-Day Free Trial | 0.27 | - | - | - | - |
NextGen Healthcare Quarterly Data | ||||||||||||||||||||
Dec18 | Mar19 | Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Days Inventory | Get a 7-Day Free Trial | - | - | - | - | - |
For the Health Information Services subindustry, NextGen Healthcare's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, NextGen Healthcare's Days Inventory distribution charts can be found below:
* The bar in red indicates where NextGen Healthcare's Days Inventory falls into.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
NextGen Healthcare's Days Inventory for the fiscal year that ended in Mar. 2023 is calculated as
Days Inventory (A: Mar. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (A: Mar. 2022 ) | + | Total Inventories (A: Mar. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Mar. 2023 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 342.013 | * | 365 |
= | 0 | / | 342.013 | * | 365 | ||||
= | 0.00 |
NextGen Healthcare's Days Inventory for the quarter that ended in Sep. 2023 is calculated as:
Days Inventory (Q: Sep. 2023 ) | |||||||||
= | Average Total Inventories | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Total Inventories (Q: Jun. 2023 ) | + | Total Inventories (Q: Sep. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Sep. 2023 ) | * | Days in Period |
= | ( (0 | + | 0) | / | 1 ) | / | 94.797 | * | 365 / 4 |
= | 0 | / | 94.797 | * | 365 / 4 | ||||
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NextGen Healthcare (NAS:NXGN) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
NextGen Healthcare's Inventory Turnover for the three months ended in Sep. 2023 is calculated as
Inventory Turnover | = | Cost of Goods Sold | / | Average Total Inventories |
= | 94.797 | / | 0 | |
= |
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
NextGen Healthcare's Inventory to Revenue for the three months ended in Sep. 2023 is calculated as
Inventory-to-Revenue | = | Average Total Inventories | / | Revenue |
= | 0 | / | 176.418 | |
= | 0.00 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Thank you for viewing the detailed overview of NextGen Healthcare's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Three Prong Investments, Llc | 10 percent owner | 1695 VIKING RD, LAGUNA BEACH CA 92651 |
David A Metcalfe | officer: Chief Technology Officer | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Mitchell Waters | officer: EVP, Commercial Growth | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Craig A. Barbarosh | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
David Ahmadzai | officer: Chief Accounting Officer | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Donna Cullen Greene | officer: EVP, Human Resources | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Srinivas S Velamoor | officer: EVP, Business Development | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
David William Sides | officer: President and CEO | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Arnold James Robert Jr. | officer: Chief Financial Officer | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Darnell Dent | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Pamela Puryear | director | 253 DOLPHIN COVE QUAY, STAMFORD CT 06902 |
Geraldine Mcginty | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Lonnie Allen Plunk | officer: EVP, Operations | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
John R Frantz | officer: CEO and President | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
Lance Rosenzweig | director | 3525 PIEDMONT RD., NE, BUILDING 6, SUITE 700, ATLANTA GA 30305 |
From GuruFocus
By PRNewswire • 08-24-2023
By PRNewswire • 09-06-2023
By Business Wire • 08-24-2023
By Marketwired • 09-12-2023
By Marketwired • 09-28-2023
By Business Wire • 09-25-2023
By GuruFocus Research • 09-04-2023
By Business Wire • 10-24-2023
By Business Wire • 09-06-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.